Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raskind

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of the American Geriatrics Society|November 26, 1999
Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative StudyR G Logsdon, L Teri, M F Weiner, et al.
Psychoneuroendocrinology|October 25, 2003
Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older menM M Cherrier, S Plymate, S Mohan, et al.
Journal of the American Geriatrics Society|May 14, 1999
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case seriesA Lim, D Tsuang, W Kukull, et al.
Neurobiology of Aging|March 1, 1989
Potential use of nerve growth factor to treat Alzheimer's diseaseC H Phelps, F H Gage, J H Growdon, et al.
Neuroendocrinology|August 26, 1999
Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and genderS Craft, S Asthana, G Schellenberg, et al.
Neurology|April 12, 2003
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled studyO M Wolkowitz, J H Kramer, V I Reus, et al.
Journal of Neurotrauma|November 3, 2020
Repetitive Blast Promotes Chronic Aversion to Neutral Cues Encountered in the Peri-Blast EnvironmentAbigail G Schindler, Garth E Terry, Tami Wolden-Hanson, et al.
Archives of General Psychiatry|December 11, 1999
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucoseS Craft, S Asthana, J W Newcomer, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of the American Geriatrics Society|November 26, 1999
Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative StudyR G Logsdon, L Teri, M F Weiner, et al.
Psychoneuroendocrinology|October 25, 2003
Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older menM M Cherrier, S Plymate, S Mohan, et al.
Journal of the American Geriatrics Society|May 14, 1999
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case seriesA Lim, D Tsuang, W Kukull, et al.
Neurobiology of Aging|March 1, 1989
Potential use of nerve growth factor to treat Alzheimer's diseaseC H Phelps, F H Gage, J H Growdon, et al.
Neuroendocrinology|August 26, 1999
Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and genderS Craft, S Asthana, G Schellenberg, et al.
Neurology|April 12, 2003
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled studyO M Wolkowitz, J H Kramer, V I Reus, et al.
Journal of Neurotrauma|November 3, 2020
Repetitive Blast Promotes Chronic Aversion to Neutral Cues Encountered in the Peri-Blast EnvironmentAbigail G Schindler, Garth E Terry, Tami Wolden-Hanson, et al.
Archives of General Psychiatry|December 11, 1999
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucoseS Craft, S Asthana, J W Newcomer, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 5